Relistor so expensive?

Why is Relistor so costly despite generic options becoming available?

Relistor, a medication used to treat opioid-induced constipation, has been a subject of discussion due to its high cost. According to a report by DrugPatentWatch.com [1], Relistor's patent expiration is in 2028.

Cost comparison with generic alternatives

While generic versions of Relistor have become available, their prices remain relatively high. The generic drug, methylnaltrexone bromide, is available at a lower cost than the brand-name version. However, the actual cost to patients often varies depending on insurance coverage and the pharmacy they visit.

Why are pharmaceutical companies resisting cheaper pricing options?

Pharmaceutical companies, including Valeant Pharmaceuticals (the owner of Relistor's patent), may resist cheaper pricing options due to revenue considerations. According to research, Valeant has increased the price of its medications significantly over the years, sparking controversy and criticism [2].

What are the alternatives for patients unable to afford Relistor?

Patients struggling to afford Relistor may consider other alternatives, such as prescription opioids or medications not approved for constipation but used off-label for opioid-induced constipation. However, these options are often not as effective and may have adverse effects.

Timeline for patent expiration and potential price drops

Relistor's patent is set to expire in 2028 [1], which may lead to an increase in generic competition and potentially lower prices. However, the exact timeline and pricing impact are still uncertain [3].

Sources:

[1] DrugPatentWatch.com - Relistor Patent Expiration Date
[2] Stat News - Valeant's Price Hike Sparks Controversy
[3] FDA - Relistor Prescribing Information

Note: The exact cost of Relistor and generic alternatives may vary depending on the location, insurance coverage, and other factors.